Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-02-09 Purchase |
2021-02-10 4:31 pm |
BIOGEN INC. | BIIB | Mantas Jesus B Director |
898 | $267 | $239,766 | 2,943 (Direct) |
View |
| 2020-11-30 Purchase |
2020-12-01 4:57 pm |
BIOGEN INC. | BIIB | Vounatsos Michel Chief Executive Officer |
3,100 | $241.31 | $748,047 | 34,810 (Direct) |
View |
| 2020-11-04 Sale |
2020-11-06 9:39 pm |
BIOGEN INC. | BIIB | Sandrock Alfred EVP, Research & Development |
1,500 | $350 | $525,000 | 13,066 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-02-12 Tax Withholding |
2021-02-17 4:54 pm |
N/A N/A |
BIOGEN INC. | BIIB | Galdes Alphonse EVP Pharmaceutical Oper & Tech |
715 | $278.03 | 17,956 (Direct) |
View |
| 2021-02-12 Exercise |
2021-02-17 4:54 pm |
N/A 2021-02-12 |
BIOGEN INC. | BIIB | Galdes Alphonse EVP Pharmaceutical Oper & Tech |
1,573 | $0 | 17,956 (Direct) |
View |
| 2021-02-12 Other |
2021-02-17 4:54 pm |
N/A 2021-02-12 |
BIOGEN INC. | BIIB | Galdes Alphonse EVP Pharmaceutical Oper & Tech |
2,071 | $0 | 17,956 (Direct) |
View |
| 2021-02-12 Tax Withholding |
2021-02-17 4:52 pm |
N/A N/A |
BIOGEN INC. | BIIB | ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec |
3,896 | $278.03 | 65,689 (Direct) |
View |
| 2021-02-12 Exercise |
2021-02-17 4:52 pm |
N/A 2021-02-12 |
BIOGEN INC. | BIIB | ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec |
4,355 | $0 | 65,689 (Direct) |
View |
| 2021-02-12 Other |
2021-02-17 4:52 pm |
N/A 2021-02-12 |
BIOGEN INC. | BIIB | ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec |
5,573 | $0 | 65,689 (Direct) |
View |
| 2020-08-03 Ownership |
2021-02-09 4:15 pm |
N/A N/A |
BIOGEN INC. | BIIB | Posner Brian S Director |
125 | $0 | 7,760 (Direct) |
View |
| 2020-12-31 Ownership |
2021-02-09 4:14 pm |
N/A N/A |
BIOGEN INC. | BIIB | PANGIA ROBERT W Director |
16,000 | $0 | 20,632 (Indirect) |
View |
| 2021-01-27 Option Award |
2021-01-29 4:47 pm |
N/A N/A |
BIOGEN INC. | BIIB | ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec |
4,545 | $0 | 41,117 (Direct) |
View |
| 2021-01-27 Option Award |
2021-01-29 4:45 pm |
N/A N/A |
BIOGEN INC. | BIIB | Galdes Alphonse EVP Pharmaceutical Oper & Tech |
818 | $0 | 4,415 (Direct) |
View |
| 2021-01-27 Option Award |
2021-01-29 4:44 pm |
N/A N/A |
BIOGEN INC. | BIIB | Gregory Ginger EVP, Human Resources |
2,558 | $0 | 7,249 (Direct) |
View |
| 2021-01-27 Option Award |
2021-01-29 4:43 pm |
N/A N/A |
BIOGEN INC. | BIIB | Sandrock Alfred EVP, Research & Development |
3,728 | $0 | 16,794 (Direct) |
View |
| 2021-01-27 Option Award |
2021-01-29 4:41 pm |
N/A N/A |
BIOGEN INC. | BIIB | Vounatsos Michel Chief Executive Officer |
16,343 | $0 | 51,153 (Direct) |
View |
Ownership |
2021-01-11 4:30 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | BIOGEN INC. Biogen MA Inc. 10% Owner |
0 | $0 | 6,241,473 (Indirect) |
View |
| 2020-12-03 Exercise |
2020-12-07 9:08 pm |
N/A 2021-12-03 |
BIOGEN INC. | BIIB | Kramer Robin VP, Chief Accounting Officer |
74 | $0 | 831 (Direct) |
View |
| 2020-12-03 Tax Withholding |
2020-12-07 9:08 pm |
N/A N/A |
BIOGEN INC. | BIIB | Kramer Robin VP, Chief Accounting Officer |
22 | $244.09 | 831 (Direct) |
View |
| 2020-12-03 Other |
2020-12-07 9:08 pm |
N/A 2021-12-03 |
BIOGEN INC. | BIIB | Kramer Robin VP, Chief Accounting Officer |
102 | $0 | 831 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-03 5:41 pm |
N/A 2020-12-01 |
BIOGEN INC. | BIIB | Guindo Chirfi EVP Glob. Prod Strat and Comm |
481 | $0 | 4,483 (Direct) |
View |
| 2020-12-01 Tax Withholding |
2020-12-03 5:41 pm |
N/A N/A |
BIOGEN INC. | BIIB | Guindo Chirfi EVP Glob. Prod Strat and Comm |
562 | $243.16 | 4,483 (Direct) |
View |
| 2020-12-01 Other |
2020-12-03 5:41 pm |
N/A 2020-12-01 |
BIOGEN INC. | BIIB | Guindo Chirfi EVP Glob. Prod Strat and Comm |
693 | $0 | 4,483 (Direct) |
View |
Ownership |
2020-09-28 4:30 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | BIOGEN INC. Biogen MA Inc. 10% Owner |
0 | $0 | 13,310,243 (Indirect) |
View |
| 2020-09-01 Option Award |
2020-09-03 5:17 pm |
N/A 2023-09-01 |
BIOGEN INC. | BIIB | MCDONNELL MICHAEL R EVP, Chief Financial Officer |
24,135 | $0 | 24,135 (Direct) |
View |
Ownership |
2020-08-20 4:21 pm |
N/A N/A |
BIOGEN INC. | BIIB | MCDONNELL MICHAEL R EVP, Chief Financial Officer |
0 | $0 | 0 (Direct) |
View |